Diab Care 45 , 909918 (2022)
We typically recommend a 24 week break after 812 weeks on for chronic protocols the necessity isn't fully established, but it's a sensible conservative approach for long-term use
Participation depends on provider review and medical appropriateness
GLP-1 receptor agonists, targeting the entero-insular axis, mimic the insulin-boosting effects of bariatric surgery
A supervised plan can help patients understand whether symptoms are expected, whether the dose should be adjusted, whether labs or vital signs should be reviewed, and whether nutrition or bowel support needs to be changed
Seek immediate medical attention for signs of severe allergic reaction including difficulty breathing, facial swelling, or widespread urticaria